Clinical Trials Directory

Trials / Completed

CompletedNCT02308449

Iron Status and Human Metabolism

Effects of Endogenous Iron Status and Intravenous Iron on Human Skeletal Muscle Metabolism at Rest and During Exercise

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
29 (actual)
Sponsor
University of Oxford · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Iron deficiency is common in cardiorespiratory diseases and appears to contribute to a worse outcome. This human physiology study will examine the extent to which human skeletal muscle metabolism and exercise physiology are impaired by iron deficiency.

Detailed description

This is a prospective double-blind randomised controlled study of the effect of endogenous iron status on skeletal muscle metabolism and exercise physiology. 32 healthy volunteers will take part, half of whom will be iron-deficient. The study involves a screening visit and two half-day visits during which assessments are performed. 50% of each group will be randomised to receive iron-repletion with ferric carboxymaltose at the end of the first experimental visit before returning to repeat identical assessments around one week later. This approach will make it possible to explore whether baseline differences in skeletal muscle metabolism are explained by differences in iron status per se, whilst controlling for any learning effect during participation in the study.

Conditions

Interventions

TypeNameDescription
DRUGFerric carboxymaltoseInfusion of 15 mg/kg (up to maximum 1000 mg) ferric carboxymaltose in 250 mL 0.9% sodium chloride
DRUGSodium chloride (placebo)Infusion of 250 mL 0.9% sodium chloride

Timeline

Start date
2014-10-01
Primary completion
2015-12-01
Completion
2016-01-01
First posted
2014-12-04
Last updated
2022-07-19

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02308449. Inclusion in this directory is not an endorsement.